1. Khan DA. Allergic rhinitis and asthma: epidemiology and common pathophysiology. Allergy Asthma Proc 2014; 35: 357-61.
2.
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 Suppl 86: 8-160.
3.
Bro¿ek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol 2017; 140: 950-8.
4.
Asher MI, Keil U, Anderson HR, et al. International Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995; 8: 483-91.
5.
Burney PGJ, Luczynska C, Chinn S, et al. The European Community Respiratory Health Survey. Eur Respir J 1994; 7: 954-60.
6.
https://ginasthma.org/wp-content/uploads/2023/07/GINA-2023-Full-report-23_07_06-WMS.pdf (access 3.10.2023).
7.
Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92: 44-7.
8.
Samoliñski B, Sybilski AJ, Raciborski F, et al. Prevalence of rhinitis in Polish population according to the ECAP (Epidemiology of Allergic Disorders in Poland) study. Otolaryngol Pol 2009; 63: 324-30.
9.
Zalewska M, Furmañczyk K, Jaworski S, et al. The prevalence of asthma and declared asthma in Poland on the basis of ECAP survey using correspondence analysis. Comput Math Methods Med 2013; 2013: 597845.
10.
Sybilski AJ, Zalewska M, Furmañczyk K, et al. The prevalence of sensitization to inhalant allergens in children with atopic dermatitis. Allergy Asthma Proc 2015; 36: e81-5.
11.
Wojas O, Krzych-Fa³ta E, Lisiecka-Bie³anowicz M, et al. Asthma as a social problem requiring systemic solutions in Poland. Adv Dermatol Allergol 2022; 39: 928-33.
12.
The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351: 1225-32.
13.
ISAAC Steering Committee. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12: 315-35.
14.
Weiland SK, Björkstén B, Brunekreef B, et al. Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J 2004; 24: 406-12.
15.
Asher MI, Montefort S, Björkstén B, et al. ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-43. Erratum in: Lancet 2007; 370: 1128.
16.
Wijs LA, Doherty DA, Keelan JA, et al. Asthma and allergies in a cohort of adolescents conceived with ART. Reprod Biomed Online 2022; 45: 1255-65.
17.
Kurosaka F, Terada T, Tanaka A, et al. Risk factors for whe-
18.
ezing, eczema and rhinoconjunctivitis in the previous
19.
12 months among six-year-old children in Himeji City, Japan: food allergy, older siblings, day-care attendance and parental allergy history. Allergol Int 2011; 60: 317-30.
20.
Kim DH, Lim DH, Samra M, et al. How accurate are the ISAAC questions for diagnosis of allergic rhinitis in Korean children? Int J Environ Res Public Health 2018; 15: 1527.
21.
Braun-Fahrländer C, Wüthrich B, Gassner M, et al. Validation of a rhinitis symptom questionnaire (ISAAC core questions) in a population of Swiss school children visiting the school health services. SCARPOL-team. Swiss Study on Childhood Allergy and Respiratory Symptom with respect to Air Pollution and Climate. International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 199; 8: 75-82.
22.
Asher MI, García-Marcos L, Pearce NE, et al. Trends in worldwide asthma prevalence. Eur Respir J 2020; 56: 2002094.
23.
AlShareef SM. Validation of the Arabic version of the European Community Respiratory Health Survey Screening Questionnaire. J Asthma Allergy 2023; 16: 735-42.